Document is current
Any future updates will be listed below
-
Authors
Vachova, Marta https://orcid.org/0000-0002-8158-724X
Stastna, Dominika https://orcid.org/0000-0003-2418-4847
Mazouchova, Aneta https://orcid.org/0000-0003-0398-9419
Hruskova, Pavla
Uher, Tomas https://orcid.org/0000-0003-3160-9022
Preiningerova Lizrova, Jana https://orcid.org/0000-0003-0337-3462
Potuznik, Pavel https://orcid.org/0000-0001-8241-7798
Drahota, Jiri https://orcid.org/0000-0003-3416-2094
Kubala Havrdova, Eva https://orcid.org/0000-0002-9543-4359
-
Funding
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (MH CZ-DRO-VFN64165)
Agentura Pro Zdravotnický Výzkum České Republiky (AZV NU22-04-00193)
- License Information
-
More Information
Article History
Received: 4 February 2025
Accepted: 4 October 2025
First Online: 23 December 2025
Declarations
:
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M. Vachova received compensation for travel and/or conference fees and/or consulting fees and/or speaker honoraria from Biogen, Merck, Novartis, Roche, Sanofi, and Teva; D. Stastna received financial support for conference travel and/or speaker honoraria and/or consulting fees from Novartis, Biogen, Merck, Bayer, Janssen-Cilag, and Pfizer; P. Potuznik received compensation for travel and/or speaker honoraria and/or consultant fees from Biogen, Novartis, Merck, Roche, and Sanofi. J. Drahota received speaker honoraria from Novartis and Roche; E. Kubala Havrdova received speaker honoraria, compensation for travel, and consultant fees from Biogen, Merck, Novartis, Sanofi, and Teva, as well as support for research activities from Biogen and Merck; none of the other authors has any conflict of interest to disclose.
